Adrenal oligometastasis cured with stereotactic ablative radiotherapy
Stereotactic ablative radiotherapy (SABR) has emerged as an effective, noninvasive alternative to surgery in patients with oligometastatic disease. Historically, select patients with adrenal oligometastases have been treated with adrenalectomies which can offer durable local control and reasonable s...
Main Authors: | Julia Malone, BSC, Jason R. Pantarotto, MD FRCPC, David Tiberi, MD FRCPC, Shawn Malone, MD FRCPC |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Radiology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1930043320304489 |
Similar Items
-
Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma
by: Rohit K. Raj, et al.
Published: (2023-12-01) -
Late metastatic presentation is associated with improved survival and delayed wide‐spread progression after ablative stereotactic body radiotherapy for oligometastasis
by: Xuguang Chen, et al.
Published: (2021-09-01) -
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
by: Philipp Hoegen, et al.
Published: (2023-03-01) -
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
by: Shankar Siva, et al.
Published: (2018-10-01) -
First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer
by: Anjali Zarkar, et al.
Published: (2023-07-01)